EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Current Approaches and Future Directions for the Treatment of mTORopathies

Vasiliki Karalis, Helen S Bateup

Developmental Neuroscience · 2021 · 43 (3-4) · 143-158

DOI: 10.1159/000515672 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Developmental Neuroscience, online erschienen am 28.04.2021. Verfasst von Vasiliki Karalis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California, USA. Hauptthemen laut MEDLINE: Autism Spectrum Disorder. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanistic target of rapamycin (mTOR) is a kinase at the center of an evolutionarily conserved signaling pathway that orchestrates cell growth and metabolism. mTOR responds to an array of intra- and extracellular stimuli and in turn controls multiple cellular anabolic and catabolic processes. Aberrant mTOR activity is associated with numerous diseases, with particularly profound impact on the nervous system. mTOR is found in two protein complexes, mTOR complex 1 (mTORC1) and 2 (mTORC2), which are governed by different upstream regulators and have distinct cellular actions. Mutations in genes encoding for mTOR regulators result in a collection of neurodevelopmental disorders known as mTORopathies. While these disorders can affect multiple organs, neuropsychiatric conditions such as epilepsy, intellectual disability, and autism spectrum disorder have a major impact on quality of life. The neuropsychiatric aspects of mTORopathies have been particularly challenging to treat in a clinical setting. Current therapeutic approaches center on rapamycin and its analogs, drugs that are administered systemically to inhibit mTOR activity. While these drugs show some clinical efficacy, adverse side effects, incomplete suppression of mTOR targets, and lack of specificity for mTORC1 or mTORC2 may limit their utility. An increased understanding of the neurobiology of mTOR and the underlying molecular, cellular, and circuit mechanisms of mTOR-related disorders will facilitate the development of improved therapeutics. Animal models of mTORopathies have helped unravel the consequences of mTOR pathway mutations in specific brain cell types and developmental stages, revealing an array of disease-related phenotypes. In this review, we discuss current progress and potential future directions for the therapeutic treatment of mTORopathies with a focus on findings from genetic mouse models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderAnimalsHumansMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2MiceQuality of LifeSignal Transduction

Stichwörter der Autor:innen

EpilepsyNeurodevelopmental disordersPTENRapamycinRaptorRictorTuberous sclerosis complexmTORC1mTORC2mTORopathy

Substanzen

Mechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2

Autor:innen und Institutionen

  • Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California, USA.
  • Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, California, USA.
  • Chan Zuckerberg Biohub, San Francisco, California, USA.

Förderung

  • NINDS NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Karalis, V., & Bateup, H. S. (2021). Current Approaches and Future Directions for the Treatment of mTORopathies. Developmental Neuroscience, 43(3-4), 143-158. https://doi.org/10.1159/000515672

Vancouver

Karalis V, Bateup HS. Current Approaches and Future Directions for the Treatment of mTORopathies. Developmental Neuroscience. 2021;43(3-4):143-158. doi:10.1159/000515672

BibTeX
@article{Karalis2021,
  author = {Karalis, Vasiliki and Bateup, Helen S},
  title = {Current Approaches and Future Directions for the Treatment of mTORopathies},
  journal = {Developmental Neuroscience},
  year = {2021},
  volume = {43},
  number = {3-4},
  pages = {143--158},
  doi = {10.1159/000515672}
}
Kostenlos starten →